We are live on ! Find out more
JGGDR

JGP Global Gestao de Recursos Portfolio holdings

AUM $45.3M
1-Year Est. Return 42.75%
This Fund
S&P 500
This Quarter Est. Return
+13.1%
1 Year Est. Return
+42.75%
3 Year Est. Return
+205.51%
5 Year Est. Return
+441.7%
10 Year Est. Return
+707.39%
AUM
$26.6M
AUM Growth
-$156M
Cap. Flow
-$158M
Cap. Flow %
-595.57%
Top 10 Hldgs %
47.03%
Holding
70
New
9
Increased
9
Reduced
27
Closed
25

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.81M
2
AAPL icon
Apple
AAPL
+$722K
3
RUN icon
Sunrun
RUN
+$258K
4
MOH icon
Molina Healthcare
MOH
+$224K
5
TFX icon
Teleflex
TFX
+$209K

Sector Composition

Rank Sector Weight
1 Healthcare 84.97%
2 Technology 11.11%
3 Consumer Staples 0%
4 Communication Services 0%
5 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUM icon
26
Humana
HUM
$46.3B
$424K 1.59%
1,034
+38
+4% +$15.8K
MRK icon
27
Merck
MRK
$323B
$405K 1.52%
5,191
+815
+19% +$62.3K
DXCM icon
28
DexCom
DXCM
$33.1B
$400K 1.5%
4,328
-224
-5% -$20K
ELV icon
29
Elevance Health
ELV
$86.2B
$396K 1.49%
1,234
-28
-2% -$8.59K
HOLX
30
DELISTED
Hologic
HOLX
$386K 1.45%
5,299
-56
-1% -$3.95K
BMY icon
31
Bristol-Myers Squibb
BMY
$132B
$374K 1.41%
6,028
-410
-6% -$25.2K
AZN icon
32
AstraZeneca
AZN
$251B
$364K 1.37%
3,639
+111
+3% +$11.8K
LLY icon
33
Eli Lilly
LLY
$1.1T
$345K 1.3%
2,046
+221
+12% +$33K
WST icon
34
West Pharmaceutical
WST
$24.8B
$309K 1.16%
1,092
-28
-3% -$7.86K
RUN icon
35
Sunrun
RUN
$2.37B
$288K 1.08%
+4,150
New +$258K
NBIX icon
36
Neurocrine Biosciences
NBIX
$16.8B
$272K 1.02%
2,841
-71
-2% -$6.86K
QDEL icon
37
QuidelOrtho
QDEL
$937M
$263K 0.99%
1,463
-68
-4% -$15.1K
SRPT icon
38
Sarepta Therapeutics
SRPT
$1.81B
$262K 0.99%
1,538
-106
-6% -$15.7K
TFX icon
39
Teleflex
TFX
$5.89B
$233K 0.88%
+566
New +$209K
MOH icon
40
Molina Healthcare
MOH
$10.4B
$230K 0.86%
+1,083
New +$224K
SAGE
41
DELISTED
Sage Therapeutics
SAGE
$226K 0.85%
+2,618
New +$193K
RARE icon
42
Ultragenyx Pharmaceutical
RARE
$2.64B
$220K 0.83%
+1,586
New +$188K
XLRN
43
DELISTED
Acceleron Pharma
XLRN
$220K 0.83%
+1,718
New +$201K
IOVA icon
44
Iovance Biotherapeutics
IOVA
$2.9B
$211K 0.79%
+4,544
New +$180K
COO icon
45
Cooper Companies
COO
$14.9B
$207K 0.78%
2,284
-116
-5% -$9.95K
ACAD icon
46
Acadia Pharmaceuticals
ACAD
$5.07B
-22,916
Closed -$945K
ALNY icon
47
Alnylam Pharmaceuticals
ALNY
$29B
-1,426
Closed -$208K
AMRN
48
Amarin Corp
AMRN
$299M
-1,094
Closed -$92K
AMZN icon
49
Amazon
AMZN
$3T
-5,100
Closed -$803K
BAC icon
50
Bank of America
BAC
$447B
-9,000
Closed -$217K

Similar funds

JGP Global Gestao de Recursos's Q4 2020 Portfolio in Review

As of Q4 2020, JGP Global Gestao de Recursos held 70 positions worth $26.6M, down 85% from $183M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

JGP Global Gestao de Recursos withdrew a net $158M in Q4 2020, closing 25 positions and reducing 27 holdings. Its most notable exit was Mercado Libre, an estimated $39.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, JGP Global Gestao de Recursos opened a new position in Microsoft worth $1.87M.

  • JGP Global Gestao de Recursos's largest Q4 2020 buy was Microsoft: 8,407 shares worth $1.87M.
  • JGP Global Gestao de Recursos added most to Merck in Q4 2020, an estimated $62.3K increase.
  • JGP Global Gestao de Recursos's biggest Q4 2020 reduction was iShares Biotechnology ETF, cutting an estimated $445K.
  • JGP Global Gestao de Recursos fully exited Mercado Libre in Q4 2020, selling an estimated $39.9M.
  • JGP Global Gestao de Recursos's ten largest holdings make up 47% of its $26.6M portfolio in Q4 2020.
  • JGP Global Gestao de Recursos opened 9 new positions and closed 25 in Q4 2020.
  • JGP Global Gestao de Recursos's portfolio value fell 85% quarter-over-quarter to $26.6M.

Based on JGP Global Gestao de Recursos's 13F filing for Q4 2020, filed 27 Jan 2021.